Your browser doesn't support javascript.
Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study.
Robertson, Elaine; Reeve, Kelly S; Niedzwiedz, Claire L; Moore, Jamie; Blake, Margaret; Green, Michael; Katikireddi, Srinivasa Vittal; Benzeval, Michaela J.
  • Robertson E; MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, UK.
  • Reeve KS; Understanding Society, Institute for Social and Economic Research, University of Essex, UK.
  • Niedzwiedz CL; Institute of Health & Wellbeing, College of Medical, Veterinary and Life Sciences, University of Glasgow, UK.
  • Moore J; Understanding Society, Institute for Social and Economic Research, University of Essex, UK.
  • Blake M; Ipsos MORI UK Ltd, UK.
  • Green M; MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, UK.
  • Katikireddi SV; MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, UK; Public Health Scotland, UK. Electronic address: Vittal.Katikireddi@glasgow.ac.uk.
  • Benzeval MJ; Understanding Society, Institute for Social and Economic Research, University of Essex, UK.
Brain Behav Immun ; 94: 41-50, 2021 05.
Article in English | MEDLINE | ID: covidwho-1126699
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups. The 'Understanding Society' COVID-19 survey asked participants (n = 12,035) their likelihood of vaccine uptake and reason for hesitancy. Cross-sectional analysis assessed vaccine hesitancy prevalence and logistic regression calculated odds ratios. Overall vaccine hesitancy was low (18% unlikely/very unlikely). Vaccine hesitancy was higher in women (21.0% vs 14.7%), younger age groups (26.5% in 16-24 year olds vs 4.5% in 75 + ) and those with lower education levels (18.6% no qualifications vs 13.2% degree qualified). Vaccine hesitancy was high in Black (71.8%) and Pakistani/Bangladeshi (42.3%) ethnic groups. Odds ratios for vaccine hesitancy were 13.42 (95% CI6.86, 26.24) in Black and 2.54 (95% CI1.19, 5.44) in Pakistani/Bangladeshi groups (compared to White British/Irish) and 3.54 (95% CI2.06, 6.09) for people with no qualifications versus degree. Urgent action to address hesitancy is needed for some but not all ethnic minority groups.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Female / Humans Country/Region as subject: Europa Language: English Journal: Brain Behav Immun Journal subject: Allergy and Immunology / Brain / Psychophysiology Year: 2021 Document Type: Article Affiliation country: J.bbi.2021.03.008

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Female / Humans Country/Region as subject: Europa Language: English Journal: Brain Behav Immun Journal subject: Allergy and Immunology / Brain / Psychophysiology Year: 2021 Document Type: Article Affiliation country: J.bbi.2021.03.008